Foscarnet

Base Information Edit

Chemical Name:Foscarnet
CAS No.:4428-95-9
Molecular Formula:CH3 O5 P
Molecular Weight:126.006
Hs Code.:2931900090
UNII:364P9RVW4X
DSSTox Substance ID:DTXSID0048478
Nikkaji Number:J11.016G
Wikipedia:Foscarnet
Wikidata:Q420387
NCI Thesaurus Code:C71630
RXCUI:33562
Metabolomics Workbench ID:42868
ChEMBL ID:CHEMBL666
Mol file:4428-95-9.mol

Synonyms:Foscarnet;Foscarnet Barium (2:3) Salt;Foscarnet Calcium (2:3) Salt;Foscarnet Disodium Salt;Foscarnet Magnesium (2:3) Salt;Foscarnet Manganese (2+) (2:3) Salt;Foscarnet Sodium;Foscarnet Sodium Hexahydrate;Foscarnet Trilithium Salt;Foscarnet Tripotassium Salt;Foscarnet Trisodium Salt;Foscavir;Phosphonoformate;Phosphonoformic Acid;Trisodium Phosphonoformate

Suppliers and Price of Foscarnet

Supply Marketing:Edit

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

American Custom Chemicals Corporation
FOSCARNET 95.00%
5MG
$ 627.63

American Custom Chemicals Corporation
FOSCARNET 95.00%
10MG
$ 610.02

American Custom Chemicals Corporation
FOSCARNET 95.00%
1MG
$ 590.61

Total 2 raw suppliers

Chemical Property of Foscarnet Edit

Chemical Property:

Vapor Pressure:5.7E-11mmHg at 25°C
Boiling Point:490.7°Cat760mmHg
Flash Point:250.6°C
PSA：104.64000
Density:2.142g/cm³
LogP:-0.15790
XLogP3:-2
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:1
Exact Mass:125.97181019
Heavy Atom Count:7
Complexity:120

Purity/Quality:

98%Min ^*data from raw suppliers

FOSCARNET 95.00% ^*data from reagent suppliers

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:: SDS file from LookChem

Useful:

Drug Classes:Antiviral Agents
Canonical SMILES:C(=O)(O)P(=O)(O)O
Recent ClinicalTrials:Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
Recent EU Clinical Trials:Phase II study, multicenter, prospective, open label, preemptive treatment of cytomegalovirus (CMV) infection driven by virologic monitoring and quantification of T CD8pp65/IE-1-IFNgamma+ lymphocytes in allogeneic hematopoietic transplantation
Recent NIPH Clinical Trials:Foscarnet therapy (90 mg/kg) to prevent HHV-6 encephalitis in umbilical cord blood transplant recipients
Therapeutic Function Antiviral

Technology Process of Foscarnet

There total 2 articles about Foscarnet which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield: